Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Federal University of São Paulo
With
Fundação de Amparo à Pesquisa do Estado de São Paulo
The early detection of additional risk factor for cardiovascular diseases (CVD) such as endothelial dysfunction and low number of EPC in SLE patients, and an intervention proven effective could reduce the cardiovascular morbidity and mortality. No study assessed the effect of ramipril on endothelial function and EPCs in SLE patients.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
SLE according 1997 modified American College Rheumatology criteria
age older than 18 years
stable treatment for lupus for at least 3 months
You may not be if
previous coronary artery disease
hypertension
dyslipidemia (LDL\>149 mg/dL)
renal insufficiency (creatinine ≥1.4 mg/dL)
diabetes
smoking
obesity (BMI≥30)
pregnancy
menopause
patients taking statins or angiotensin convertor enzyme inhibitor within the last 6 months
Clareo Health | Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus
